Celebrating 50 years of scientific
advancement –
learn more
Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Notice of orphan drug designation for JR-446 for mucopolysaccharidosis type IIIB by Ministry of Health, Labour and Welfare of Japan
September 29, 2025
|
In
News
|
By
Moises Zanetti
Download PDF
Back to Newsroom
Privacy Preference Center
Privacy Preferences